ArticleGynecologic oncology2021
Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019.
Article in Gynecologic oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06431724 (A Prospective Analysis of Adherence to National Cervical Cancer Screening Recommendations in Women Age >65), which is not on this map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Prospective Analysis of Adherence to National Cervical Cancer Screening Recommendations in Women Age >65
Who cites it
22 citing papers in PubMed, 29 citations in OpenAlex.
- Predictors of routine HPV-based cervical cancer screening adoption in federally qualified health centers within a multi-state practice research network 2012-2022: retrospective observational study.BMC primary care · 2026Observational
- Declines in cervical cancer incidence among young women in the United States.Journal of the National Cancer Institute · 2026Article
- Trends in over- and under-screening for cervical cancer after EMR implementation in rural China.NPJ digital medicine · 2026Article
- Cervical cancer screening and prevalence among older US Medicare beneficiaries with and without HIV.International journal of cancer · 2026Article
- Cervical screening-using implementation science tools to maximise impact in a complex world.Gynecology and pelvic medicine · 2026Article
- Nonadherence to Cervical Cancer Screening Guidelines in Commercially Insured US Adults, 2013-2021.JAMA network open · 2025Article
- Use of Cancer Screening Tests, United States, 2023.Preventing chronic disease · 2025Article
- Trends in cervical cancer screening modality in the active component U.S. military, 2013-2023.MSMR · 2025Article
- Perceptions of a Diverse Group of U.S. Women on the Ease of Vaginal Self-Sampling for Cancer Detection.Women's health reports (New Rochelle, N.Y.) · 2025Article
- Race/Ethnicity, Human Papillomavirus Vaccination Status, and Papanicolaou Test Uptake Among 27-45-Year-Old Women: A Cross-Sectional Analysis of 2019-2022 Behavioral Risk Factor Surveillance System Data.Women's health reports (New Rochelle, N.Y.) · 2025Article
- Primary human papillomavirus testing by clinician- versus self-collection: Awareness and acceptance among cervical cancer screening-eligible women.Journal of medical screening · 2024Article
- Tubal Sterilization and Cervical Cancer Underscreening in the United States.Journal of women's health (2002) · 2024Article
- Sexual Orientation and Cervical Cancer Screening Among Cisgender Women.JAMA network open · 2024Article
- Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health System.American journal of preventive medicine · 2024Article
- Small-cell neuroendocrine carcinoma of the cervix with leptomeningeal spread: A rare coincidence report and literature review.Surgical neurology international · 2024Article
- HPV self-sampling among women in the United States: preferences for implementation.Cancer causes & control : CCC · 2024Article
- Factors associated with shorter-interval cervical cancer screening for young women in three United States healthcare systems.Preventive medicine reports · 2023Article
- Lack of Awareness of Human Papillomavirus Testing Among U.S. Women.American journal of preventive medicine · 2023Article
- Article
- Provider beliefs in effectiveness and recommendations for primary HPV testing in 3 health-care systems.JNCI cancer spectrum · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
objectiveTo examine trends in the use of cervical cancer screening tests during 2013-2019 among commercially insured women.
methodsThe study population included women of all ages with continuous enrollment each year in the IBM MarketScan commercial or Medicare supplemental databases and without known history of cervical cancer or precancer (range = 6.9-9.8 million women per year). Annual cervical cancer screening test use was examined by three modalities: cytology alone, cytology plus HPV testing (cotesting), and HPV testing alone. Trends were assessed using 2-sided Poisson regression.
resultsUse of cytology alone decreased from 34.2% in 2013 to 26.4% in 2019 among women aged 21-29 years (P < .0001). Among women aged 30-64 years, use of cytology alone decreased from 18.9% in 2013 to 8.6% in 2019 (P < .0001), whereas cotesting use increased from 14.9% in 2013 to 19.3% in 2019 (P < .0001). Annual test use for HPV testing alone was below 0.5% in all age groups throughout the study period. Annually, 8.7%-13.6% of women aged 18-20 years received cervical cancer screening. There were persistent differences in screening test use by metropolitan residence and census regions despite similar temporal trends.
conclusionsTemporal changes in the use of cervical cancer screening tests among commercially insured women track changes in clinical guidelines. Screening test use among individuals younger than 21 years shows that many young women are inappropriately screened for cervical cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.